LONG-TERM EFFECTS OF ETANERCEPT AND CERTOLIZUMAB PEGOL TREATMENT ON VASCULAR FUNCTION AND LIPID PARAMETERS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS

被引：2
|
作者：
Vegh, Edit [1 ]
Vancsa, Andrea [1 ,2 ]
Kerekes, Gyoergy
Balazs, Fruzsina [1 ]
Pogacsas, Lilla [1 ]
Bodnar, Nora [1 ]
Szuecs, Gabriella [1 ]
Szanto, Sandor [1 ]
Szekanecz, Zoltan [1 ]
机构：
[1] Univ Debrecen, Med & Hlth Sci Ctr, Inst Med, Dept Rheumatol, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Dept Angiol, H-4012 Debrecen, Hungary
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2013-205124.82
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1.83
引用
收藏
页码：A36 / A37
页数：6
相关论文
共 50 条
  • [31] Patient Satisfaction and Experience with Golimumab, Adalimumab, and Etanercept for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Bolge, Susan
    Eldridge, Helen
    Doshi, Dilesh
    Ellis, Lorie
    Roland, Barbara
    Woelfel, John
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S817 - S817
  • [32] SUSTAINED LONG-TERM EFFICACY OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: A 2-YEAR ANALYSIS OF THE RAPID 1 STUDY
    Smolen, Josef
    Keystone, Ed
    Schiff, Michael
    Mease, Philip
    van Vollenhoven, Ronald
    Desai, Chintu
    RHEUMATOLOGY, 2009, 48 : I85 - I86
  • [33] LONG-TERM TREATMENT OF RHEUMATOID SPONDYLITIS WITH INDOMETHACIN
    BLOCHMIC.H
    ROUAUD, JP
    ARZNEIMITTEL-FORSCHUNG, 1971, 21 (11A): : 1872 - &
  • [34] Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    MODERN RHEUMATOLOGY, 2015, 25 (01) : 11 - 20
  • [35] LONG-TERM EFFICACY AND SAFETY OF ARTHROTEC IN PATIENTS WITH RHEUMATOID-ARTHRITIS, OSTEOARTHRITIS OR ANKYLOSING-SPONDYLITIS
    KOCHMAN, RL
    GEIS, GS
    GAGNIER, RP
    STEAD, H
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 179 - 179
  • [36] Rheumatoid Factor Predicts Long-Term Retention Associated With Effectiveness of Certolizumab Pegol in Patients With Rheumatoid Arthritis: A Two-Center Retrospective Study
    Mutoh, Tomoyuki
    Okazaki, Soshi
    Shirai, Tsuyoshi
    Sato, Hiroko
    Ohtsu, Susumu
    Ishii, Tomonori
    Fujii, Hiroshi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (03)
  • [37] Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
    Vivian P. Bykerk
    Peter Nash
    David Nicholls
    Yoshiya Tanaka
    Kevin Winthrop
    Christina Popova
    Nicola Tilt
    Derek Haaland
    Rheumatology and Therapy, 2023, 10 : 693 - 706
  • [38] Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
    Bykerk, Vivian P. P.
    Nash, Peter
    Nicholls, David
    Tanaka, Yoshiya
    Winthrop, Kevin
    Popova, Christina
    Tilt, Nicola
    Haaland, Derek
    RHEUMATOLOGY AND THERAPY, 2023, 10 (03) : 693 - 706
  • [39] Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
    Brandt, J
    Listing, J
    Haibel, H
    Sörensen, H
    Schwebig, A
    Rudwaleit, M
    Sieper, J
    Braun, J
    RHEUMATOLOGY, 2005, 44 (03) : 342 - 348
  • [40] Long-term efficacy, including halting of radiographicprogression, and safety of etanercept in patients with ankylosing spondylitis
    Dijkmans, B.
    Sridharan, S.
    Fatenejad, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 187 - 187
12345